$ cat ./records/doctors-without-borders-faults-the-gates-backed-vaccine-model-ove-2015.txt
Doctors Without Borders Faults the Gates-Backed Vaccine Model Over Pneumonia-Shot Prices
[RECORD.TXT] · cat --full
In 2015, Médecins Sans Frontières (Doctors Without Borders) launched its 'A Fair Shot' campaign accusing Pfizer and GlaxoSmithKline of keeping the pneumococcal vaccine — protection against the leading infectious killer of young children — too expensive for poorer countries. MSF criticized the financing model of Gavi, the vaccine alliance co-founded and heavily funded by the Gates Foundation, arguing it subsidized the two manufacturers' duopoly and high prices rather than driving costs down, and it pressed for a price of $5 per child. After a global petition, the companies cut prices for humanitarian use in 2016. The campaign reflected broader criticism that the Gates-backed approach to global vaccination can prioritize industry interests.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Resists Fossil-Fuel Divestment Even as His Foundation Holds Oil Stocks
Next →
Gates Sides With Musk and Hawking, Voicing Concern Over Superintelligent AI
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.